Bio-Path Holdings, Inc. (BPTH) vs Jaguar Animal Health, Inc. (JAGX)
- Bio-Path Holdings, Inc. BPTH 0.00 NaN
- Jaguar Animal Health, Inc. JAGX 0.40 −2.44%
Bio-Path Holdings, Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. is the larger, with a market value of $1.1M against $950.0K — 1.1× the size. Bio-Path Holdings, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 14 metrics below, Bio-Path Holdings, Inc. leads on 10 and Jaguar Animal Health, Inc. on 4.
Valuation
Profitability
| Metric | BPTH | JAGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 82.31% | 68.51% |
| Operating margin | 0.00% | (93.10%) | 0.00% |
| Net margin | 0.00% | (188.46%) | 0.00% |
| Free cash flow margin | 0.00% | (24.03%) | 0.00% |
| Return on equity | 157.01% | (1,125.38%) | (51.96%) |
| Return on assets | (605.50%) | (127.14%) | (46.06%) |
| Return on invested capital | 0.00% | (28,393.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack